Nephrolithiasis/nephrocalcinosis: genes and variants
Explore variant evidence for Nephrolithiasis/nephrocalcinosis across 2 analyzed proteins (CASR, OCRL). Linked ClinVar records include 14 pathogenic or likely pathogenic variants, 526 variants of uncertain significance and 93 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Nephrolithiasis/nephrocalcinosis
CASR: Extracellular calcium-sensing receptor
It senses extracellular calcium in the parathyroid gland and kidney and adjusts parathyroid-hormone secretion and renal calcium handling accordingly. Loss-of-function variants cause familial hypocalciuric hypercalcemia or neonatal severe hyperparathyroidism, whereas activating variants cause autosomal dominant hypocalcemia.
14 ClinVar pathogenic / likely pathogenic and 576 uncertain variants in CASR have source records linked to Nephrolithiasis/nephrocalcinosis. Association strength is not clinical gene validity.
OCRL: Inositol polyphosphate 5-phosphatase OCRL
It dephosphorylates specific phosphoinositides on endosomal and Golgi membranes and thereby regulates membrane trafficking, actin dynamics, and primary-cilium function. Loss-of-function variants cause Lowe syndrome and Dent disease type 2.
0 ClinVar pathogenic / likely pathogenic and 43 uncertain variants in OCRL have source records linked to Nephrolithiasis/nephrocalcinosis. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Nephrolithiasis/nephrocalcinosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CASR F788C | 788 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| CASR G143R | 143 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| CASR P55L | 55 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| CASR E767K | 767 | Extracellular | Pathogenic / likely pathogenic (★★) |
| CASR R66H | 66 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| CASR R69H | 69 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| CASR F128L | 128 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| CASR T138M | 138 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| CASR D217Y | 217 | Ligand-binding 2 (LB2) | Pathogenic / likely pathogenic (★★) |
| CASR R465Q | 465 | Extracellular | Pathogenic / likely pathogenic (★★) |
| CASR I555T | 555 | Cysteine-rich (CR) | Pathogenic / likely pathogenic (★★) |
| CASR F612S | 612 | Transmembrane | Pathogenic / likely pathogenic (★) |
| CASR Y829C | 829 | Extracellular | Pathogenic / likely pathogenic (★) |
| CASR M1L | 1 | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in Nephrolithiasis/nephrocalcinosis
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| CASR R66L | 66 | Ligand-binding 1 (LB1) | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; R66H at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.733 |
Which prediction tools work for Nephrolithiasis/nephrocalcinosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 95 out of 100
- phyloP: 94 out of 100
- CADD: 91 out of 100
- VARITY: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 88 out of 100
- MetaLR: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 74 out of 100
- phastCons: 71 out of 100
Same protein, different disease
- Familial hypocalciuric hypercalcemia also has ClinVar records linked to CASR variants; they fall mostly in different places as the Nephrolithiasis/nephrocalcinosis variants (81 pathogenic / likely pathogenic).
- Autosomal dominant hypocalcemia also has ClinVar records linked to CASR variants; they fall mostly in different places as the Nephrolithiasis/nephrocalcinosis variants (69 pathogenic / likely pathogenic).
- Neonatal severe primary hyperparathyroidism also has ClinVar records linked to CASR variants; they fall partly in the same places as the Nephrolithiasis/nephrocalcinosis variants (11 pathogenic / likely pathogenic).
- Idiopathic generalized epilepsy also has ClinVar records linked to CASR variants; they fall partly in the same places as the Nephrolithiasis/nephrocalcinosis variants (8 pathogenic / likely pathogenic).
- Familial hyperparathyroidism or Hypocalciuric hypercalcaemia also has ClinVar records linked to CASR variants; they fall mostly in different places as the Nephrolithiasis/nephrocalcinosis variants (5 pathogenic / likely pathogenic).
Diseases related to Nephrolithiasis/nephrocalcinosis
- Hypertrophic cardiomyopathy, also linked to CASR
- Familial hypocalciuric hypercalcemia, also linked to CASR
- Autosomal dominant hypocalcemia, also linked to CASR
- Idiopathic generalized epilepsy, also linked to CASR
- Dent disease, also linked to OCRL
- Lowe syndrome, also linked to OCRL
- Neonatal severe primary hyperparathyroidism, also linked to CASR
- Familial hyperparathyroidism or Hypocalciuric hypercalcaemia, also linked to CASR
- Parathyroid carcinoma, also linked to CASR
- Familial hypoparathyroidism, also linked to CASR
Frequently asked questions
Which genes have records linked to Nephrolithiasis/nephrocalcinosis?
This view contains 2 analyzed proteins: CASR, OCRL. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 14 pathogenic or likely pathogenic variants, 526 variants of uncertain significance and 93 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 652 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center